Results 141 to 150 of about 21,053 (285)

Anticoagulation treatment and prophylactic edoxaban for cerebral sinus venous thrombosis in an adolescent with acute lymphoblastic leukemia [PDF]

, 2021
Masaya Koganesawa, Ryosuke Matsuno, Yumiko Sugishita, Ryota Kaneko, Naoko Kawabata, Sachio Fujita, Kosuke Akiyama, Daisuke Toyama, Shohei Yamamoto   +8 more
openalex   +1 more source

Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE [PDF]

, 2015
Introduction: The current mainstay of the treatment of thrombotic antiphospholipid syndrome (APS) is long-term anticoagulation with vitamin K antagonists (VKAs) such as warfarin. Non-VKA oral anticoagulants (NOACs), which include rivaroxaban, have been
Clawson, S, Cohen, H, Doré, CJ, Hunt, BJ, Isenberg, D, Khamashta, M, Muirhead, N, RAPS Trial Protocol Collaborators, .   +7 more
core   +1 more source

Prevalence, risk characteristics, and prediction of low-dose edoxaban treatment in hospitalized patients: a multicenter, observational cohort study

Frontiers in Pharmacology
BackgroundTreatment with a low-dose non-vitamin K antagonist oral anticoagulant (NOAC) is common among hospitalized patients, and a model to predict the need for such treatment would support individualized interventions.
Shujuan Zhao, Hengfen Dai, Jiaxin Chen, Ming Ni, Wenxing Peng, Xiaoyu Li, Fen Li, Boya Chen, Haixia Cai, Yinping Liu, Song Du   +10 more
doaj   +1 more source

Design of Experiment Mediated Development of Stability Indicating High Performance Thin Layer Chromatography Method Invoking Failure Mode Effect Analysis Based Risk Assessment in Estimation of Edoxaban Tosylate Monohydrate [PDF]

, 2022
Vrunda Balvantbhai Mistry, Hitika Bharatbhai Patel, Praful Pravinchandra Dedhiya, Kunjan B. Bodiwala, Sandesh Lodha, Shrikant V. Joshi, Gajanan Govindrao Kalyankar   +6 more
openalex   +1 more source

Edoxaban in venous thromboembolism and stroke prevention: an appraisal

Vascular Health and Risk Management, 2016
Marco Proietti,1,2 Gregory YH Lip1,3 1University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK; 2Department of Internal Medicine and Medical Specialties, Sapienza-University of Rome, Rome, Italy; 3Aalborg Thrombosis ...
Proietti M, Lip GYH
doaj  

Edoxaban

Reactions Weekly, 2022
  +5 more sources

Edoxaban in cardiovascular disease management: Review [PDF]

, 2021
Sharanyah Srinivasan, Muhammad Ajmal, Cristina Pecci, Tom Lassar   +3 more
openalex   +1 more source

Edoxaban: front-line treatment for brachiocephalic vein thrombosis in primitive mediastinal seminoma: A case report and literature review

, 2022
Agnese Maria Fioretti, Tiziana Leopizzi, Agata Puzzovivo, Francesco Giotta, Vito Lorusso, Giovanni Luzzi, Stefano Oliva   +6 more
openalex   +1 more source

Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism [PDF]

, 2017
Anticoagulation for the long-term treatment and prevention of thrombo-embolic diseases as well as for stroke prevention in atrial fibrillation (AF) has been accomplished by vitamin K antagonists for the last half century. Although effective under optimal
Braunwald, Eugene, Steffel, Jan
core  

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2019
G. Raskob, N. Es, P. Verhamme, M. Carrier, M. Nisio, David A. Garcia, Hokusai Vte Cancer Investigators   +6 more
semanticscholar   +1 more source